Breber Pierre R 4

What Happened
Pierre R. Breber, a director of The Clorox Company (CLX), received two awards of deferred stock units (DSUs) reported on Form 4. On 2026-02-13 he was credited with 27.05 DSUs (price $0.00), and on 2026-03-31 he was credited with 325.678 DSUs (price $0.00), for a total of 352.728 DSUs. These were awards (transaction code A) and carry no immediate cash value in the filing because they are derivative units to be settled in stock.

Key Details

• Transaction dates: 2026-02-13 (27.05 DSUs) and 2026-03-31 (325.678 DSUs). Report filed 2026-04-02.
• Price reported: $0.00 per unit; total cash consideration shown as $0 (these are compensation/derivative units, not open-market purchases).
• Shares owned after transaction: Not specified in the Form 4 provided.
• Footnotes: F1 = 1-for-1; F2 = DSUs acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan; F3 = DSUs will be settled 100% in Clorox stock upon the director’s retirement/termination; F4 = DSUs received in lieu of quarterly director fees.
• Timeliness: The Mar 31 grant was reported within the typical 2-business-day window (filed Apr 2). The Feb 13 grant appears to have been reported late (filed Apr 2), which is noted in the filing — late Form 4s can draw SEC attention or administrative penalties but do not by themselves indicate trading intent.

Context
Deferred stock units are a form of director compensation that convert to company shares (here, 1-for-1) upon retirement or termination and are not the same as an open-market purchase or sale. Such awards are routine for non-employee directors and do not necessarily signal a personal buy/sell decision about the company’s near-term prospects.